Considering the cumulative risk of mixtures of chemicals – A challenge for policy makers by Sarigiannis, Denis A & Hansen, Ute
REVIEW Open Access
Considering the cumulative risk of mixtures of
chemicals – A challenge for policy makers
Denis A Sarigiannis
1,2*, Ute Hansen
1
From HENVINET (Health and Environment Network) final conference
Brussels, Belgium. 14 April 2010 - 15 April 2010
Abstract
Background: The current paradigm for the assessment of the health risk of chemical substances focuses primarily
on the effects of individual substances for determining the doses of toxicological concern in order to inform
appropriately the regulatory process. These policy instruments place varying requirements on health and safety
data of chemicals in the environment. REACH focuses on safety of individual substances; yet all the other facets of
public health policy that relate to chemical stressors put emphasis on the effects of combined exposure to
mixtures of chemical and physical agents. This emphasis brings about methodological problems linked to the
complexity of the respective exposure pathways; the effect (more complex than simple additivity) of mixtures (the
so-called ‘cocktail effect’); dose extrapolation, i.e. the extrapolation of the validity of dose-response data to dose
ranges that extend beyond the levels used for the derivation of the original dose-response relationship; the
integrated use of toxicity data across species (including human clinical, epidemiological and biomonitoring data);
and variation in inter-individual susceptibility associated with both genetic and environmental factors.
Methods: In this paper we give an overview of the main methodologies available today to estimate the human
health risk of environmental chemical mixtures, ranging from dose addition to independent action, and from
ignoring interactions among the mixture constituents to modelling their biological fate taking into account the
biochemical interactions affecting both internal exposure and the toxic potency of the mixture.
Results: We discuss their applicability, possible options available to policy makers and the difficulties and potential
pitfalls in implementing these methodologies in the frame of the currently existing policy framework in the
European Union. Finally, we suggest a pragmatic solution for policy/regulatory action that would facilitate the
evaluation of the health effects of chemical mixtures in the environment and consumer products.
Conclusions: One universally applicable methodology does not yet exist. Therefore, a pragmatic, tiered approach to
regulatory risk assessment of chemical mixtures is suggested, encompassing (a) the use of dose addition to calculate a
hazard index that takes into account interactions among mixture components; and (b) the use of the connectivity
approach in data-rich situations to integrate mechanistic knowledge at different scales of biological organization.
Background
The current paradigm for the assessment of the health risk
of chemical substances focuses primarily on the effects of
individual substances for determining the doses of toxico-
logical concern in order to inform appropriately the
regulatory process. Given the recently increased public
awareness on the link between environmental conditions
and public health, the policy-making and environmental
management processes have an enhanced need for health
and safety data. In Europe, this was signalled in the 6th
Environmental Action Plan (2001-2010), where for the
first time the issue of environment and health was identi-
fied as a key determinant of sustainability. Since then, a
number of legislative initiatives have been undertaken in
the European Union with a scope to reducing the potential
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as a key dimension for ensuring sustainability. These
include
(a) Consumer Policy and REACH, the current chemi-
cal safety regulation in the European Union, requiring
sound data on chemical safety of consumer products [1];
(b) Environment & Health Action Plan putting parti-
cular emphasis on mixture effects in various environ-
mental matrices [2];
(c) Food safety policies regarding chemicals in food
and food contact materials [3].
These policy instruments place varying requirements
on health and safety data of chemicals in the environ-
ment. REACH focuses on safety of individual sub-
stances; yet all the other facets of public health policy
that relate to chemical stressors put emphasis on the
effects of combined exposure to mixtures of chemical
and physical agents. This emphasis brings about metho-
dological problems linked to the complexity of the
respective exposure pathways; the effect (more complex
than simple additivity) of mixtures (the so-called ‘cock-
tail effect’); dose extrapolation, i.e. the extrapolation of
the validity of dose-response data to dose ranges that
extend beyond the levels used for the derivation of the
original dose-response relationship; and the integrated
use of toxicity data across species (including human
clinical, epidemiological and biomonitoring data).
In this paper we give an overview of the main methodol-
ogies available today to estimate the human health risk of
environmental chemical mixtures, ranging from dose addi-
tion to independent action, and from ignoring interactions
among the mixture constituents to modelling their biolo-
gical fate taking into account the biochemical interactions
affecting both internal exposure and the toxic potency of
the mixture. We discuss the possible options available to
policy makers and the difficulties and potential pitfalls in
implementing these methodologies in the frame of the
currently existing policy framework in the European
Union. Finally, we suggest a plausible scenario for policy/
regulatory action that would facilitate the evaluation of the
health effects of chemical mixtures in the environment
and consumer products.
Mixture toxicology methods
As described in the text above, from a mixture toxicology
point of view each methodology to predict cumulative
effects or to detect interactions has limited applicability
under specific conditions that cannot be generalized.
Information on mode and mechanism of action for each
active substance in the mixture is needed to decide
whether to use dose or effect addition, while biochemical
and molecular pathway information regarding enzyme
activity and the ADME (absorption – distribution –
metabolism – excretion) properties of the substances are
needed to determine the existence or not of these pro-
cesses and the level of biochemical interactions among
them. In risk assessment and management, however, a
more pragmatic viewpoint is taken, and given the overall
uncertainties of the process an approximation to the
cumulative effects is usually good enough, for example a
worst-case, but not overly conservative, estimate. One
key issue is, nonetheless, the need to render the risk
assessment transparent by recognizing and reporting
explicitly on the uncertainty and the assumptions asso-
ciated with each of the risk assessment methodologies
described below and in the next chapter (see Figure 1).
Hazard index
The hazard index (HI) of a mixture of chemicals is the
sum of the compound-specific hazard quotients (HQi),
w h i c ha r ec a l c u l a t e da st h er a t i oo ft h ee x p o s u r e( e . g .
the daily intake of a substance) to the dose of no con-
cern (i.e. the exposure above which adverse effects on
human health can be expected) [4-7]. This reference
dose (refi) can be, for example, the acceptable daily
intake (ADI) or the acute reference dose (ARfD).
The hazard index for a mixture of several substances
Si (i = 1,2,…n) can be calculated as
HI
ref
i
i i
n

 
exp
.
1
(9)
The hazard index method does not allow prediction of
the overall health effect of the combined substances but
adds the strength of risk (roughly estimated), attributa-
ble to each component of the mixture. If the index
exceeds unity the concern is the same as if an individual
chemical exposure exceeded its acceptable level by the
same proportion [4]. The hazard index can be used to
identify the most risky substances in a mixture, i.e. the
chemicals that have the highest health risks based on
toxic potential and estimated or measured exposure.
Feron et al [5] propose to use the Mumtaz-Durkin and
Mumtaz et al [6,7] weight of evidence approach, which
is based on the hazard index concept but additionally
considers evidence for interactions for the selection of
the most risky chemicals or groups of chemicals in a
complex mixture (see below).
Risk prediction using the HI approach is based on a
comparison of specific exposure to the substance-speci-
f i ce x p o s u r el i m i t ,r e f i, for each component of the mix-
ture. If this exposure limit is derived from testing effects
on an identical physiological target, e.g. effects on a cer-
tain enzyme measured under defined conditions, the
result obtained is equivalent to the outcome of the dose
summation method. A kind of effect addition is per-
formed through the HI calculation if the refi values refer
Sarigiannis and Hansen Environmental Health 2012, 11(Suppl 1):S18
http://www.ehjournal.net/content/11/S1/S18
Page 2 of 12to a more general endpoint, induced by similar or dis-
similar mechanisms, e.g. if refi values are threshold con-
centrations above which adverse effects on the liver are
expected. It allows prediction of even more general risk
indices. If for the first compound of a mixture a refi is
available for lung cancer, for the second the refi refers
to liver cancer and the third component is known to
enhance the risk to a third type of cancer, a risk index,
named Health Risk Index, can be calculated for the gen-
eral category “cancer”. It should be noted that expi and
refi should refer to the same time scale of exposure in
terms of chronic versus acute exposure and toxicity, and
to the same uptake route, because, for example, the
amount of a toxic substance taken up with food may
n o tb ed i r e c t l yc o m p a r e dt ot h et o x i c i t yt h r e s h o l d
derived from an inhalation study.
The hazard index concept has the advantage that it is
transparent and easy to apply [8-10]. The disadvantage
is that the reference to which exposure is related does
n o ts o l e l yr e f l e c tt h et o x i c i t yo ft h es u b s t a n c eb u ti s
derived by using uncertainty factors which are not fully
data based but may incorporate significant policy-driven
assumptions: For calculating reference concentrations of
no concern (refi) the NOAELs usually are divided by a
factor accounting for the uncertainty of the generalisa-
tion of the NOAEL as specified also in the respective
technical annex of the REACH Regulation. If the
NOAEL is known only for a low number of species/
trophic groups this assessment factor is high and the
resulting threshold is low. If testing has been performed
for several species and trophic groups extrapolation
from test species to humans is more reliable. In this
case the assessment factor is lower so that the reference
value deviates to a lesser extent from the NOAEL.
Point of departure index
The point of departure index (PODI) method does not
have the disadvantage of the hazard index, as exposure
is compared to a concentration level reflected by toxicity
data. The point of departure index is the sum of the
Figure 1 Scheme of risk assessment approaches Scheme of risk assessment approaches. Currently methodology is available for substance by
substance toxicology and the assessment of mixtures of substances with the same mechanism of action for which dose or concentration
addition is applied.
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point of departure (POD),
PODI
POD
i
i i
n

 
exp
1
(10)
where the POD can be a NOAEL, the dose at which a
toxic effect becomes biologically significant, or a bench-
mark dose [11,12]. The benchmark dose method is a
statistical tool fitting a mathematical model to all the
dose-response data within a study and thus more biolo-
gical information is used for the derivation of the POD
compared to the traditional NOAEL derivation [12].
The benchmark dose (BMD) method provides additional
information regarding its uncertainty but high quality
dose response curves are required in order to provide
estimated BMDs with small confidence intervals [10].
For the evaluation of potential risk the PODI of a mix-
ture is compared to an agreed group safety factor. This
factor is often 100 and the product of PODI and the
uncertainty factor should be <1 [10].
Margin of exposure
T h em a r g i no fe x p o s u r e( M O E )o fas u b s t a n c ei st h e
NOAEL divided by exposure so that the combined mar-
gin of exposure of a mixture (MOEmix) can be calcu-
lated as
MOE
MOE MOE MOE
mix
n
  







11 1
12
1
... (11)
T h em a r g i no fe x p o s u r ei n d e xo fam i x t u r ei sc o m -
pared to an agreed acceptable threshold. According to
EFSA [10] there are no established criteria for the mag-
nitude of an acceptable MOEmix for mixtures of chemi-
cals but it is widely accepted that at a MOEmix higher
than the uncertainty factor of 100 the conclusion can be
drawn that the risk of toxicity is unlikely.
Cumulative risk index
The cumulative risk index (CRI) combines MOEs for
chemicals with different uncertainty factors. The risk
index (RI) of a single chemical is the reciprocal of the
hazard quotient and is calculated as
RI
NOAEL
UF
ref
i
i
ii
i
i



exp exp
, (12)
where UF is the uncertainty factor mentioned above
(e.g. [10]). The reference dose (refi) can be, for example,
the acceptable daily intake,A D I .T h ec u m u l a t i v er i s k
index (CRI) of a mixture of chemicals is defined as
CRI
ref
i
i i
n

  1
1
/
exp
. (13)
The cumulative risk index is the reciprocal of the
hazard index (equation 9).
Toxic equivalency factors
The Toxic Equivalence Factor (TEF) is a specific type of
relative potency factor (see section 2.2) formed through
a scientific consensus procedure [10]. Based on the
assumptions of a similar mechanism of action of struc-
turally related chemicals and parallel concentration (or
dose) response curves, TEFs were first developed for
polychlorinated dibenzo-p-dioxins (PCDDs) and poly-
chlorinated dibenzofurans (PCDFs) and polyaromatic
hydrocarbons (PAHs). The total toxicity of the mixture
is assessed in terms of the toxicity of an equivalent con-
centration of an index compound. The total equivalent
quantity TEQ is estimated by summation of the concen-
trations (or doses) of mixture components ci multiplied
by the respective TEFi:
TEQ c TEF ii
i
n

 ()
1
(14)
The TEF/RFP approach is equivalent to the MOE
approach described above (see Section 3.3). The major
difference is the stage at which to extrapolate from
experimental data to humans: for each chemical sepa-
rately (allowing different assessment factors for each
chemical) in the case of MOE; or after combining their
doses/effects (using thus one assessment factor for all
chemicals in the mixture) in the case of the TEF/RFP
approach.
Methods for risk assessment of mixtures taking
into account interactions
Toxicant interactions may take place during any of the
processes that affect the toxic potency of a single com-
pound: adsorption, distribution, metabolism, excretion
and activity at the receptor site(s). They may interact
chemically, and they may interact by causing different
effects at different receptor sites [4]. Interactions can be
assumed to occur frequently and often are dose-depen-
dent but, according to EFSA [7], there is no standard
study design to evaluate the potential interaction of
compounds. Evidence exists that mixtures having addi-
tive toxicity at low, environmentally relevant concentra-
tions show synergism at higher exposure. This was
shown for effects of pesticides mixtures on a target
enzyme extracted from tissue of salmon [13]. At EC50
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EC50, respectively.
Most commonly, dose additivity is considered the
expected outcome when testing for the effects of chemi-
cal mixtures; any deviations thereof are deemed interac-
tions. However, this is not necessarily the case, as
deviations from additivity may also be observed in
absence of interactions [14]. Experimental observations
of deviations from additivity have been reported,
although Kortenkamp et al. [15] report them as being
quite rare. Nesnow et al. [16] analysed mixture effects of
five polycyclic aromatic hydrocarbons on lung tumours
in A/J mice, with mixture ratios representative of ambi-
ent air levels of these carcinogens. At low doses greater
than additive effects were seen, whereas at high doses
the observed responses fell short of additivity expecta-
tions which were derived from independent action in an
effect surface analysis. However, the observed deviations
from effect addition were rather small.
Another example is the study by Walker et al. [17] who
employed two year rodent cancer bioassays with female
Harlan Sprague-Dawley rats given 2,3,7,8-tetrachlorodi-
benzo-p-dioxin (TCDD), 3,3’,4,4’,5-pentachlorobiphenyl
(PCB-126), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF),
or a mixture of the three compounds. The three chemi-
cals, both singly and in combination, induced hepatic,
lung and oral mucosal neoplasms. A re-analysis of the
data, without utilizing the WHO TEF values [10] but by
employing the concept of dose addition directly, showed
that the experimentally observed tumor incidences fell
short of those anticipated by dose addition [15].
T h e r ea r eaf e we x a m p l e sf r o mt h ea r e ao fe n d o c r i n e
disruption that indicated antagonisms in the joint effects
of estrogenic agents [18], but these deviations were
rather small. Similarly, the study by Hass et al. [19] on
the feminizing effects of androgen receptor antagonists
on male offspring of dams dosed during gestation indi-
cated a weak synergism with respect to induction of nip-
ple retention. Similar deviations from additivity were not
observed with other endpoints evaluated in the same
study.
Even though on many an occasion deviation from
dose additivity may not be easy to observe at low, envir-
onmentally relevant doses, this may be mostly due to
the sensitivity and the binary (effect or no effect) nature
of classic toxicological tests. The advent of –omics and
in particular transcriptomics opens the way to identify-
ing deviations from the assumption of additive response
to co-exposure to chemical substances. Toxicogenomics
seems to be the appropriate screening method for asses-
sing biological effects of complex chemical mixtures,
allowing us to review the whole spectrum of potential
biological response rather than focusing on a predefined
number of endpoints as in classical toxicological
analysis. Applying such techniques Coccini et al. [20]
showed a distinct modulation in the muscarinic receptor
density and gene expression associated with neurological
response in rats co-exposed to methyl mercury and
PCB153 perinatally. Cimino Reale et al. [21] studied
comparatively the mixture effects of typical mixtures
found in indoor air in Europe and of a mixture of poly-
aromatic hydrocarbons (PAHs) sampled in Milan, Italy.
Large sets of genes modulated by exposure to different
air mixtures were profiled and common biochemical
pathways and specific molecular responses were identi-
fied. Indoor air mixtures induced a higher gene modula-
tion than PAHs, confirming major differences in the
toxic mode of action of the two mixtures. Indoor air
induced primarily modulation of genes associated with
protein targeting and localization including in particular
cytoskeletal organization; PAHs modulated mostly the
expression of genes related to cell motility and gene net-
works regulating cell-cell signaling, as well as cell prolif-
eration and differentiation. These results provide
biological information useful for articulating mechanistic
hypotheses of exposure to xenobiotic mixtures and phy-
siological responses.
One way to deal with the general lack of knowledge
about interactions in a cumulative risk assessment con-
text is to use an additional uncertainty factor accounting
for potential synergy effects. As mentioned above,
NOAELs usually are divided by assessment factors con-
sidering, for example, the uncertainty of extrapolation of
data gained with certain test organisms in the lab to
toxicity thresholds applicable for human health protec-
tion (factor = 10) and the between humans differences
in sensitivity (factor = 10). Increasing the uncertainty
factor by a factor of 10 and thus accounting for interac-
tions of chemicals in a mixture would cover a tenfold
increase in mixture toxicity due to interactions between
the mixture components. Not much is known about the
significance and extent of synergy effects and it is
unclear whether an uncertainty factor of 10 would be
protective or over-protective. Currently no specific
assessment factor for mixtures is employed in the tradi-
tional chemical-by-chemical risk assessment [5].
Interactions based hazard index
A modified hazard index approach has been proposed
[10], using the hazard index developed for additive
effects as a basis and accounting for interactions by
multiplying the HI with a factor reflecting both the
uncertainty and the strength of evidence that interac-
tions take place. The interaction-based hazard index
(HII) is calculated as:
HI HI UF II
WOEN  (15)
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WOEN is a numerical weight-of-evidence score reflect-
ing the strength and consistency of evidence for interac-
tions scaled to reflect the relative importance of the
component exposure levels. The method is based on the
procedure proposed by Mumtaz and Durkin [6]. Further
developments of the HI approach yielded the following
equation for HIINT, the hazard index modified by binary
interactions data [10], applying the weight-of-evidence
procedure to modify each HQ instead of modifying the
sum of the HQ values of the mixture:
HI HQ f M INT i ij ij
B
ji
n
i
n
ij ij 
   ()

1
(16)
where HIINT is the HI modified by binary interactions
data, HQi is the hazard quotient for chemical i,f ij is the
toxic hazard of the j
th chemical relative to the total
hazard from all chemicals potentially interacting with
chemical i (thus j cannot equal i), Mij is the interaction
magnitude, the influence of chemical j on the toxicity of
chemical i,B ij is the score for the strength of evidence
that chemical j will influence the toxicity of chemical i,
and θij represents the degree to which chemicals i and j
are present in equitoxic amounts. How to derive Bij,f ij,
Mij and θij is described in detail in EPA [10].
Excluding interactions – the isobole method
Since both the dose addition and the effect summation
methods are applicable only under the precondition that
interactions are absent, methods suitable for examining
whether all mixture components act without diminish-
ing or enhancing the effects of each other play an
important role in current state of the art mixture toxi-
cology. The isobole method [10] is the most common
criterion for judging whether interactions between simi-
larly acting chemicals have taken place in a mixture
experiment [13]. Bosgra et al. [13] give an overview of
the method and discuss its applicability. The isobole
method is based on the following approach:
In the case of zero-interaction
d
d
d
d
1
1
2
2
1
’’
 (17)
where d1 and d2 are doses of the substances S1 and S2,
respectively, present in a particular combination, and d1’
and d2’ represent the doses that, if applied individually,
result in the same magnitude of effect as the combina-
tion. If the mixture has the same effect but the effect is
reached with lower d1/d1’ and/or d2/d2’ ratio(s) the left
part of equation 17 is smaller than 1, reflecting synergy
as an enhancement of toxic potency due to interaction
of the mixture components. Any deviation from 1
denotes a deviation from additivity [11].
Modelling interacting mixtures
In the past 15 years or so, physiologically based pharma-
cokinetic/pharmacodynamic (PBPK/PD) modeling has
been applied to the toxicological interactions of chemi-
cal mixtures. A comprehensive review on these studies
was conducted by Reddy et al. [22]. Progress in the
application of PBPK modeling to chemical mixtures has
followed different phases from simple binary pharmaco-
kinetic and pharmacodynamic interactions to more and
more complex mixtures. First, PBPK modeling of binary
chemical mixtures became necessary because of phar-
macological or toxicological interactions. Second, as
investigators became interested in mechanisms of toxi-
cological interactions, the advances of physiologically
based pharmacodynamic (PBPD) modeling formed a
natural course of development of this area. Third, when
more and more sophistication was incorporated into
PBPK modeling, novel approaches towards modeling
complex chemical mixtures were developed. Since 1996
when the Food Quality and Protection Act was enacted,
the United States Environmental Protection Agency (US
EPA) began to give active consideration to cumulative
risk assessment taking into account toxicological inter-
actions. Thus, the application of PBPK modeling in
cumulative risk assessment became an active area of
research [23].
Mumtaz et al. [6] in an earlier review of PBPK model-
ing of chemical mixtures indicated that the “first exam-
ple” of PBPK modeling of a “chemical mixture” actually
involved one chemical, n-hexane, and its metabolites,
methyl n-butyl ketone (MnBK) and 2,5-hexanedione
(2,5-HD); thus, it is a kind of “one-chemical mixture.”
This particular PBPK model for n-hexane and its meta-
bolites incorporated three inhibitory interactions: (1)
hexane and MnBK are competitive substrates for w-1
oxidation; (2) MnBK and 2,5-HD are competitive sub-
strates for oxidation; and (3) 2,5-HD acts as a product
feedback inhibitor [24]. The findings of this modeling
study were intriguing and they explained some of the
most interesting and complex toxicological and pharma-
cokinetic behaviors of n-hexane in animals [7].
Pioneering efforts in the PBPK modeling of more
complex chemical mixtures were from a research group
led by Krishnan and various colleagues in Canada; two
comprehensive reviews of work up to 1994 are available
[25,26]. Earlier work from this group concentrated on
interactions and PBPK modeling between two chemicals
[27,28] . As progress was made, these investigators
began to build up the mixtures and devoted their effort
to PBPK modeling of more and more complex chemical
mixtures [29-32]. PBPK modeling of a ternary mixture
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reported by Tardif et al. [29], and the interaction
mechanism involved was competitive inhibition. Subse-
quently, Haddad et al. [30]applied this interactive PBPK
model to the calculation of the biological hazard index
(BHI). BHI, defined as the biological level tolerable to
exposure to mixtures, is traditionally calculated in an
analogous way to the hazard index under the additivity
assumption [30-33]. However, Haddad et al. [30] incor-
porated toxicological interaction by using PBPK model-
ing to obtain “simulation concentrations” (SC) and
modified the hazard index calculation according to the
following equation:
BHI
SC
BEI
i
i i
n

 
1
(18)
where BHI and SC are as defined before and BEI
refers to the concentration or excretion rate of a bio-
marker in a healthy worker exposed to the occupational
t h r e s h o l dl i m i tv a l u e( T L V ) .I nd o i n gs o ,H a d d a de ta l .
[30] applied interactive PBPK modeling of a chemical
mixture into the risk assessment process. Using the
same principle and similar technique, researchers at
Colorado State University studied PBPK modeling of
two ternary mixtures [trichloroethylene (TCE), tetra-
chloroethylene (PERC), methyl chloroform (MC) and
toluene, ethyl-benzene, and xylenes] to respectively
enhance the concept of “interaction thresholds” and
modify and improve the “Mixture Formula” risk assess-
ment by using an interactive PBPK modeling approach
[34-36].
Haddad et al. [31]also studied the PBPK modeling of a
four-chemical mixture involving benzene, toluene, ethyl-
benzene, and m-xylene. In general, the incorporation of
the interaction mechanism, at the level of the liver
metabolic enzyme inhibition, is similar to those
described above for binary and ternary mixtures, albeit a
bit more complicated. In Europe, Sarigiannis and Gotti
[37] studied a similar group of volatile organic chemicals
including benzene, ethylbenzene, toluene and all the
family of xylenes (m-, o-, p-) extending the previous
work to tackle the chemical interactions and the bio-
chemical processes influencing the rate of metabolism
of the mixture compounds. They brought the methodol-
ogy one step further by taking into account the mor-
phology of the liver and its relationship with metabolic
function, as well as the mechanism of competitive inhi-
bition of metabolism to estimate the biologically effec-
tive dose (BED) of the mixture components and their
primary metabolites and then related BED for the sum
of benzene metabolites (the main carcinogenic com-
pounds in the mixture) to epidemiological and clinical
observations of health outcomes (leukemia incidence).
This allowed them to derive new dose-response relation-
ships relating the observed health response to the total
internal dose of the metabolites at the target tissue
(bone marrow in this case), rather than to the external
environmental concentrations (doses) of the chemicals
in the mixture. The result was a more biologically plau-
sible dose-response curve that captures better the phy-
siological response to toxic insults at low doses and
long-term (chronic) exposure.
As PBPK modeling of chemical mixtures progresses
towards involving more and more components, a nat-
ural course of development is that investigators will
attempt to tackle the real-world complex chemical mix-
tures. Verhaar et al. [38] proposed the incorporation of
lumping analyses (a chemical engineering technique
used in petroleum engineering processes) and quantita-
tive structure-activity relationships (QSAR) to PBPK
modeling. The idea was that each of the three techni-
ques would serve its unique function in the overall goal
of predicting some aspects of the chemical mixtures of
interest. Thus, QSAR analysis can be used to predict
needed physicochemical and toxicological parameters
for unknown compounds or for surrogate compounds
(from lumping); lumping analysis can drastically reduce
the complexity of the description of a mixture; and
PBPK/PD modeling can be used to describe the pharma-
cokinetics, and possibly pharmacodynamics, of an
ensemble of compounds or lumped pseudocompounds,
including possible interaction effects.
Grouping of chemicals by health endpoint
There is no established methodology available allowing
assessment of the endpoint-specific health risk due to a
combination of chemicals having different modes of
action and affecting the same endpoint. Although the
independent action method for response or effect addi-
tion described in detail earlier in this paper allows calcu-
lation of summed effects of mixtures of chemicals acting
via independent pathways, the applicability of this
method for integrated health impact assessment of envir-
onmental chemical stressors is limited for the following
reasons. First, dose-response relationships for the respec-
tive effect are required for each compound of the mix-
ture; these are, in many cases, available for effects on in
vitro systems or test organisms but lacking for human
health endpoints. A further complication results from the
specificity of the uptake route of the dose response rela-
tionship. A further reason for the limited applicability is
that the response addition approach can be used under
the precondition that interactions can be excluded.
Methods used to test whether no-interaction can be
assumed usually require dose-response-algorithms, which
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combinations.
The hazard index and the interactions-based hazard
index method, described above, are applied for assessing
potential health risks due to mixtures of chemicals
affecting a given health endpoint by acting with the
same or differing mode of action. Exposure is compared
to a reference exposure assumed to be acceptable in
terms of risk to human health. Although the hazard
index and related indices mentioned above are not sui-
table for giving information about the number of cases
of impaired health to be expected for a certain complex
exposure or policy scenario they represent an important
tool for risk assessment and help to decide whether
exposure of the population or subgroups to a certain
mixture of chemicals should give rise to concern.
For pesticides the suitable substance specific limit
value, i.e. the reference level (refi) of no concern, usually
is the accepted daily intake rate (ADI) relevant to
human health but not to certain health endpoints. Cal-
culating the endpoint specific health risk index for a
m i x t u r eo fp e s t i c i d e sb ys u m m i n gu pt h ee x p o s u r et o
limit value ratios requires health endpoint specific limit
values assumed to be protective for the selected end-
point. This kind of reference value, e.g. cancer health
risk limit values for humans, is usually not available for
pesticides. There are two possibilities to deal with this
problem: The first is to identify compounds of the mix-
ture affecting the same health endpoint on the basis of
available evaluations, to relate exposure to generic ADIs
instead of endpoint specific limit values, and then sum
up the ratios to derive the index value. The second pos-
sibility is to identify compounds of the mixture showing
effects when tested with a certain indicator system (e.g.
genotoxicity tests), to relate exposure to the substance
specific NOAEL derived with this test and sum up these
ratios for all components of the mixture.
Grouping of unknown mixtures of unknown substances
Grouping pesticides by effects on indicator systems is of
high importance because to date combination toxicology
is facing a generic problem: for many potentially toxic
substances produced or just present at relevant amounts
the mechanism of action is unknown and their toxicity
has not been evaluated. According to data from the US
EPA, for about 80% of substances produced at signifi-
cant amounts no toxicity information is available. For
pesticides this percentage goes down to about 40%. For
pesticides the knowledge level is relatively good but far
from being sufficient. The U.S. EPA has launched a set
of projects on chemicals risk assessment with the aim of
developing methods for the prediction of chemical toxi-
cology suitable for dealing with a high number of sub-
stances, to improve incorporation of molecular
toxicology and computational science, to reduce stan-
dard rodent toxicology tests and to increase cost effi-
ciency [39]. Complex data on chemical structures,
results of high throughput screening and rodent test
data are evaluated in order to identify groups of chemi-
cals characterised by their effects on cellular pathways
and more generic health endpoints.
With respect to mixtures the approach is based on the
identification of relationships between the structure of a
substance and its toxicity. If structural features of a sub-
stance group are correlated with toxicity revealed from
in vitro assays determined using high throughput
screening, and the same structural features are corre-
lated with in vivo toxicity test results, in vitro assay
results or even structural features might be sufficient to
predict the mechanism of action and health effects. The
approach aims at predicting the mode of action and/or
toxicity of a high number of chemicals within a short
time period. In the context of mixtures of chemicals
with unknown mode of action the methods might be
suitable to sort the compounds of a mixture by pre-
dicted modes of action in order to define groups of che-
micals for which additive combination toxicology
approaches, such as concentration or dose addition, or
hazard index related methods, can be applied.
Discussion
In tackling the health risk associated with combined
exposure to mixtures of chemicals in the environment,
the food chain and consumer goods, regulatory bodies
will have to deal with several problems:
￿ Setting maximum acceptable threshold concentra-
tions or acceptable daily intakes (ADIs) for certain che-
mical groups with a common mechanism of action such
as organophosphates would be a first step forward, but
would disregard most of the mixture constituents as the
majority of active substances in a sample usually belong
to different chemical groups (an example is given in
Table 1).
￿ Additive approaches based on grouping substances
by effects (e.g. summing up doses of compounds caus-
ing dysfunction of the nervous system in humans but
acting via differing mechanisms) requires testing
results obtained under comparable conditions and
evaluating effects on a common human health end-
point. Such data are not available in most cases, and,
again, only a part of the mixture constituents would be
considered (Table 1).
￿ Using the hazard index approach for assessing the
risk to human health is practicable and transparent but
the question arises whether HQs of all mixture com-
pounds should be added, or, alternatively, HQs of sub-
stances grouped on the basis of their relevance for a
certain health effect. Krautter et al [40]
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considering both threshold exceedances (ARfD, ADI,
MRLs) and HIs, the latter calculated as the sum of HQs
of all substances in the sample (See http://www.green-
peace.de/fileadmin/gpd/user_upload/themen/umwelt-
gifte/greenpeace_bewertung_pestizide_neu.pdf)
￿ Adding HQs of all compounds found has the advan-
tage that it is transparent and easy, but has the disad-
vantage that improving the detection limit of the
analysis and thus identifying a high number of com-
pounds present at very small amounts might increase
the overall hazard index, whereas an analysis of the
same sample with higher detection limit would indicate
a lower risk. Thus, the overall estimated risk of the mix-
ture is only dependent on the detection limit and not
on the actual biochemical mechanisms that determine
toxic potency.
￿ Adding HQs of compounds within a common health
effect would probably reveal additional information on
specific risk of the mixture, but has the disadvantage
that for most active substances currently in use the
dataset on health effects is incomplete: for three of the
13 compounds in Table 1 it is known that they have no
endocrine disrupting effects, for three it is known that
they might have these effects, but it is not clear, and for
seven others no data on endocrine disruption are
available.
￿ A further problem connected with the use of the
hazard index approach for the risk classification of mix-
tures is that a suitable reference has to be chosen. It has
to be decided whether the HQs should be calculated as
a residue versus MRL or a predicted daily dose versus
the ADI or both, and, in the case of dose versus ADI,
w h e t h e rt h ed o s e sa n dA D I sf o ra d u l t so rc h i l d r e n
should be applied.
￿ The lack of knowledge about actual or potential
synergistic interactions is a general problem. Legislation
can deal with this problem by diminishing reference
concentrations or doses of no concern by a factor
assumed to be protective, but whether this factor should
be 2, 3 or 10 is a matter of speculation.
￿ Existence of toxic metabolites and potential bio-
chemical interaction among the mixture components
influencing the level of metabolic activity complicates
further the risk assessment of mixtures. This complica-
tion is further increased when the biological half-life of
the mixture components varies significantly. Under-
standing the nature of component interactions and the
related biokinetics is a key requirement for assessing
effectively chemical mixtures with these characteristics.
To date, the effects of chemical mixtures are dealt
with by the regulatory framework in the USA, but not
in the European Union. The International Programme
on Chemical Safety of the World Health Organization
(WHO IPCS) has developed guidelines with a view to
enlarging their applicability to its domain of competence
(worldwide); both of these initiatives, however, are lim-
ited to human health effects. The current thinking
within the European Commission and in the relevant
scientific and industrial community in Europe is that
any European initiative towards the establishment of
guidelines regarding the assessment of chemical
Table 1 Plant protection products found in German fruit with corresponding health effects
active
substance
chemical group* pesticide type* target health issues*
carc end repr AChE neuro resp
Endosulfan-
sulfate
organochlorine acaricide,
insecticide
neurotoxic, affects the transfer of nerve impulses in
insects and mammals
? ? - no yes -
Chlorpyrifos-
ethyl
organophosphate insecticide AChE inhibitor, causes dysfunction of the nerval system no ? yes yes no no
Chlorpyrifos-
methyl
organophosphate acaricide,
insecticide
AChE inhibitor, causes dysfunction of the nerval system no no - yes ? no
Triadimefon triazole fungicide disrupts membrane function ? ? yes no ? -
Trifloxystrobin strobilurin fungicide inhibits electron transfer and respiration no - yes no no -
Boscalid carboxamide fungicide inhibits sperm germination ? no ? no no -
Cyprodinil anilinopyrimidine fungicide blocks certain synthesis pathways within the cells no - ? no no yes
Dimethomorph morpholine fungicide lipid synthesis inhibitor no - ? no no no
Fenhexamid hydroxyanilide fungicide Disrupts membrane function, inhibits spore germination no - no no no no
Fludioxonil phenylpyrrole fungicide inhibits phosphorylation of glucose ? - ? no no no
Fluopicolide benzamide fungicide protectant ? - no no no no
Metalaxyl phenylamide fungicide protectant suppressing infections, sporangial formation
and mycelial growth
no - no no no -
Thiametoxam neonicotinoid insecticide affect the central nervous system by binding to an
postsynaptic ACh receptor
?n o n o n on o?
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humans and the environment [41]. Such guidelines
could be built around a core of tools, methods and
approaches common to mammalian and ecological toxi-
cology, the most important of which are described in
this paper.
What type of general principles can be included in a
European Commission recommendation in order to
address combination effects?
Clearly, currently there is a need to strengthen the
legal mandate for risk assessment of mixtures. In this
context, mixture effects need to be taken into account
holistically, drawing useful lessons from the CIRCLA
legislation in the United States, targeting Superfund
sites. If an overarching framework is set based on gen-
eral guidelines and underpinned by as much scientific
rigor as possible, then more sectorial implementation
could vary to adapt to the twenty one different pieces of
European Community legislation pertinent to the issue
of chemical mixture safety, including legislation on che-
m i c a l s( R E A C H ) ,c o n s u m e ra r t i c l e s( C o n s u m e rS t r a t -
egy), plant protection products (Plant Protection
Products Directive), biocides (Biocides Directive), water
quality (Water Framework Directive and Marine Strat-
egy), and air pollution (Air Quality Framework Direc-
tive). The forthcoming WHO guidelines for indoor air
quality, currently under development in conjunction
with the European Commission, would be an opportu-
nity to incorporate thinking about risk assessment of
mixtures in a sectorial piece of legislation affecting
almost all the European population for more than 80%
of the time. In this context, a Europe-wide data center
on human exposure to environmental chemicals could
provide the necessary scientific support for effective risk
assessment of chemical mixtures. For this purpose, the
European Commission’s Joint Research Centre in colla-
boration with the European Environment Agency has
been working towards the development of this data cen-
ter since 2008. So far, the basic concept for the data
center has been developed. The available monitoring
data for cumulative exposure assessment are expected to
be pulled together by the EEA topical centres (on air,
water, soil) in the course of 2011. In the food products
domain, the European Food Safety Authority (EFSA) has
recently initiated similar efforts, while the European
Chemicals Agency (ECHA) is in the process of populat-
ing the IUCLID 5 database with physical/chemical and
toxicity data on industrial chemicals currently in the
European market. Setting up an interagency group
bringing together the efforts of all the European Union
organs would be the most efficient way towards coordi-
nated action to assess cumulative exposure assessment
to chemical mixtures.
A possible way forward to overcome the current gaps
in knowledge that could act as obstacles to the defini-
tion of a plausible regulatory approach to chemical mix-
ture risk assessment would be to use a tiered approach
as follows:
(a) Use dose addition to calculate a hazard index tak-
ing into account interactions (eq. 16) as default option
for hazard quantification and risk assessment. This
approach could be employed as default first-tier
approach for mixtures risk assessment. The formulation
of the hazard index given in eq. 16 allows taking into
account the non-linear effects from the interaction of
mixture components if the necessary information is
available, while simplifying down to a simple dose addi-
tion if no interaction data exist. Such an approach
would be in line with the current practice across the
Atlantic, as the interaction-based hazard index has been
developed and used extensively by the US Environmen-
tal Protection Agency. Overall, it would give a reason-
able approximation to the toxic potency of a mixture if
the necessary data are available; if not, it would still
allow conservative assumptions about effects of com-
bined exposure to multiple chemicals and interactions
among the mixture components.
In data-rich situations use more sophisticated tools,
including mechanistic, biology-based modeling that
takes into account the biologically effective dose of the
mixture components at the target tissues and incorpo-
rates system-wide response data across the dose-
response range using information derived from –omics
technologies – the connectivity approach [42]. This
more complex yet plausible methodology would be in
line with the United States Academy of Science 2007
report towards toxicity testing in the 21
st century [43].
The tiered approach outlined above ensures that it can
be readily applied in the current regulatory context and
yet opens up the way to incorporating scientific state of
the art in the near future. A key development that could
be implemented readily in already existing pieces of leg-
islation (during their regular review process) would be
to demand that the collected toxicity data be amenable
for mixture toxicity assessment. This means essentially
three things:
i. that toxicity data are recorded and documented in a
coherent uniform way, independent of specific regula-
tory context;
ii. that emphasis should be given to the full range of
the dose-response function, and in particular below the
NOAEL or DNEL (derived no effect level, as used in
REACH); and,
iii. that benchmark approaches should be given prefer-
ence over NOAELs or NOECs in setting up regulatory
safety limits for chemical substances.
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facilitate a rational assessment of chemical mixture toxi-
city as described above, further research is needed tar-
geting at least the following key issues:
￿ development of dedicated exposure assessment stra-
tegies for environmental chemical mixtures (e.g. follow-
ing the example of the US Geographic Survey collection
of water samples analyzing a large number of chemicals)
￿ analysis of the determinants of synergistic action (i.e.
giving answers to the question ‘when is it likely that a
mixture acts synergistically?’)
￿ identification and assessment of the chemicals that
contribute most to cumulative risk on the basis of inte-
grated assessment under specific exposure scenarios of
relevance to sectorial policies
Conclusions
This paper gives a comprehensive overview of the cur-
rently available methodological and computational tools
for assessing the health effects of chemical mixtures
with a view towards applying them in chemical safety
regulation. The salient pitfalls in converting scientific
knowledge on combination effects of co-exposure to
multiple chemicals are discussed and a tiered approach
to mixture risk assessment is outlined for use by regula-
tors and policy makers.
An EU strategy for assessing and managing combina-
tion effects of chemicals in the environment could com-
prise the following elements:
– development of guidelines on general principles;
there is a need to explain why the combination effects
of chemicals have to be addressed effectively from con-
certed policy and regulatory action based on robust
scientific grounds; there is a need to bring out the pro-
blems based on scientific evidence and to start assessing
these combination effects.
– use of the methodological tools available as outlined
in this paper. For data poor situations, dose addition
could be used as default option in a tiered approach
that moves from dose addition to fully mechanistic ana-
lysis of the possible interactions among the components
in a chemical mixture [43].
– resolution of the difficulties with dealing with the
different pieces of legislation related to the health effects
of environmental chemical mixtures and achievement of
a holistic approach. There is a clear need to address the
issue in a coordinated fashion among the European
Commission services responsible for legislation across
different media with a view to identifying the practical
steps towards achieving this integrated approach.
– further scientific research aiming at getting more
precise information on cumulative exposure to chemical
mixtures in the environment and using better the infor-
mation collected through different pieces of legislation
in order to inform policy makers’ choices and enable
them to prioritize.
Acknowledgements
The research that led to this article was co-funded by the European
Commission in the frame of the 6th RTD framework program projects
HEIMTSA (contract no. GOCE-CT-2006-036913-2) and HENVINET(contract no
GOCE-CT-2006-037019). The authors would like to thank Drs. Bo Larsen, Sieto
Bosgra, Arno Gutleb and Peter van den Hazel for very useful comments on
earlier versions of the manuscript.
This article has been published as part of Environmental Health Volume 11
Supplement 1, 2012: Approaching complexities in health and environment.
The full contents of the supplement are available online at http://www.
ehjournal.net/supplements/11/S1.
Author details
1European Commission – Joint Research Centre, Institute for Health and
Consumer Protection, Chemical Assessment and Testing, via E. Fermi 1,
21027 (VA), Italy.
2Aristotle University of Thessaloniki, Chemical Engineering
Department, Environmental Engineering Laboratory, University Campus, Bldg.
D, 50441 Thessaloniki, Greece.
Authors’ contributions
DAS supervised the study that led to this manuscript and wrote explicitly
the introduction, biological modeling, discussion and conclusions sections;
he also takes the responsibility for drafting the overall manuscript as is. UH
provided the material for the sections reviewing the current methodological
approaches for cumulative risk assessment of chemical mixtures and
contributed to the discussion.
Competing interests
The authors declare that they have no competing interests.
Published: 28 June 2012
References
1. EC: EC Regulation No 1907/2006 of the European Parliament and of the
Council of 18 December 2006 concerning the Registration, Evaluation,
Authorisation and Restriction of Chemicals (REACH). 2006.
2. EC: European environment and health action plan 2004–2010 (COM
(2004) 416). 2004.
3. EC: EC Regulation No 1935/2004: Regulation of the European Parliament
and of the Council of 27 October 2004 on materials and articles
intended to come into contact with food and repealing Directives 80/
590/EEC and 89/109/EEC. 2004.
4. EPA: United States Environmental Protection Agency, Federal Register.
1986, 51(185):34014-34025[http://www.epa.gov/oswer/riskassessment/
human_health_toxicity.htm].
5. Feron VJ, Van Vliet PW, Notten WRF: Exposure to combinations of
substances: A system for assessing health risks. Environmental Toxicology
and Pharmacology 2004, 18:215-222.
6. Mumtaz MM, Durkin PR: A weight-of-evidence approach for assessing
interactions in chemical mixtures. Toxicology and Industrial Health 1992,
8:377-406.
7. Mumtaz MM, Sipes IG, Clewell HJ, Yang RSH: Risk assessment of chemical
mixtures: Biologic and toxicologic issues. Fundamental and Applied
Toxicology 1993, 21:258-269.
8. EFSA: Development of a framework for the risk assessment of chemical
mixtures – a toxicological database on relevant chemical mixtures to
food safety. 2009 [http://www.efsa.europa.eu/en/scdocs/scdoc/42e.htm].
9. EFSA: Scientific Opinion of the Scientific Panel on Plant Protection
Products and their Residues to evaluate the suitability of existing
methodologies and, if appropriate, the identification of new approaches
to assess cumulative and synergistic risks from pesticides to human
health with a view to set MRLs for those pesticides in the frame of
Regulation (EC) 396/2005. The EFSA Journal 2008, 704:1-84.
10. EFSA: Cumulative Risk Assessment of Pesticides to human health: The
way forward. Parma European Food Safety Authority; 2006 [http://www.
efsa.europa.eu/en/supporting/pub/117e.htm].
Sarigiannis and Hansen Environmental Health 2012, 11(Suppl 1):S18
http://www.ehjournal.net/content/11/S1/S18
Page 11 of 1211. EPA: Benchmark dose technical guidance document. United States
Environmental Protection Agency; 2000 [http://www.epa.gov/oswer/
riskassessment/human_health_toxicity.htm], EPA/630/R-00/001.
12. Filipsson AF, Sand S, Nilsson J, Victorin K: The Benchmark Dose Method -
Review of Available Models, and Recommendations for Application in
Health Risk Assessment. Critical Reviews in Toxicology 2003, 33:505-542.
13. Bosgra S, Van Eijkeren JCH, Slob W: Dose addition and the isobole
method as approaches for predicting the cumulative effect of non-
interacting chemicals: A critical evaluation. Critical Reviews in Toxicology
2009, 39:418-426.
14. Kortenkamp A: State of the Art Report on Mixture Toxicity. 2009 [http://
ec.europa.eu/environment/chemicals/pdf/report_Mixture%20toxicity.pdf].
15. Laetz CA, Baldwin DH, Collier TK, Hebert V, Stark JD, Scholz NL: The
synergistic toxicity of pesticide mixtures: Implications for risk assessment
and the conservation of endangered Pacific salmon. Environmental Health
Perspectives 2009, 117:348-353.
16. Nesnow S, Mass MJ, Ross JA, Galati AJ, Lambert GR, Gennings C, Carter WH
Jr., Stoner GD: Lung tumorigenic interactions in strain A/J mice of five
environmental polycyclic aromatic hydrocarbons. Environmental Health
Perspectives 1998, 106:1337-1346.
17. Walker NJ, Crockett PW, Nyska A, Brix AE, Jokinen MP, Sells DM, Hailey JR,
Easterling M, Haseman JK, Yin M, et al: Dose-additive carcinogenicity of a
defined mixture of “dioxin-like compounds”. Environmental Health
Perspectives 2005, 113:43-48.
18. Rajapakse N, Silva E, Scholze M, Kortenkamp A: Deviation from additivity
with estrogenic mixtures containing 4-nonylphenol and 4-tert-
octylphenol detected in the E-SCREEN assay. Environmental Science and
Technology 2004, 38:6343-6352.
19. Hass U, Scholze M, Christiansen S, Dalgaard M, Vinggaard AM, Axelstad M,
Metzdorff SB, Kortenkamp A: Combined exposure to anti-androgens
exacerbates disruption of sexual differentiation in the rat. Environmental
Health Perspectives 2007, 115(Suppl 1):122-128.
20. Coccini T, Castoldi AF, Roda E, Marafante E, Cimino-Reale G, Casati B, M L:
Gender-, time- and brain area-dependent modulation of muscarinic
receptor density and gene expression in rats perinatally exposed to
methylmercury and PCB153. Toxicology Letters 2007, 172(Suppl):s179-s180.
21. Cimino-Reale G, Collotta A, Sarigiannis DA, Marafante E: Toxicogenomic
study of indoor and outdoor air chemical mixtures. Fresenius
Environmental Bulletin 2008, 17:1485-1491.
22. Reddy MB, Yang RSH, Clewell HJ III, Andersen ME: Physiologically Based
Pharmacokinetic Modeling: Science and Applications. John Wiley & Sons;
2005.
23. EPA: Physiologically-based Pharmacokinetic/Pharmacodynamic Modeling:
Preliminary Evaluation and Case Study for the N-Methyl Carbamate
Pesticides: A Consultation, December 11 and 12, 2003 FIFRA Scientific
Advisory Panel Meeting, Arlington, Virginia, SAP Minutes No. 2003-06.
2003 [http://www.epa.gov/scipoly/sap/meetings/2003/121103_mtg.htm].
24. Andersen M, Clewell H: Pharmacokinetic interactions of mixtures. 14th
Conference on Environmental Toxicology; AFAMRL-TR-83-099, Air Force
Aerospace Medical Research Laboratory Wright-Patterson AFB, OH; 1994,
226-238.
25. Krishnan K, Andersen ME, Clewell HJ III, Yang RSH: Physiologically Based
Pharmacokinetic Modeling of Chemical Mixtures. In Toxicology of
Chemical Mixtures: Case Studies, Mechanisms, and Novel Approaches. San
Diego, CA;Yang RSH 1994:399-437.
26. Krishnan K, Clewell HJ Iii, Andersen ME: Physiologically based
pharmacokinetic analyses of simple mixtures. Environmental Health
Perspectives 1994, 102:151-155.
27. Tardif R, Lapare S, Krishnan K, Brodeur J: A descriptive and mechanistic
study of the interaction between toluene and xylene in humans.
International Archives of Occupational and Environmental Health 1993, 65:
S135-S137.
28. Pelekis M, Krishnan K: Assessing the relevance of rodent data on
chemical interactions for health risk assessment purposes: A case study
with Dichloromethane-toluene mixture. Regulatory Toxicology and
Pharmacology 1997, 25:79-86.
29. Tardif R, Charest-Tardif G, Brodeur J, Krishnan K: Physiologically Based
Pharmacokinetic Modeling of a Ternary Mixture of Alkyl Benzenes in
Rats and Humans. Toxicology and Applied Pharmacology 1997, 144:120-134.
30. Haddad S, Tardif R, Viau C, Krishnan K: A modeling approach to account
for toxicokinetic interactions in the calculation of biological hazard
index for chemical mixtures. Toxicology Letters 1999, 108:303-308.
31. Haddad S, Tardif R, Charest-Tardif G, Krishnan K: Physiological modeling of
the toxicokinetic interactions in a quaternary mixture of aromatic
hydrocarbons. Toxicology and Applied Pharmacology 1999, 161:249-257.
32. Haddad S, Charest-Tardif G, Tardif R, Krishnan K: Validation of a
physiological modeling framework for simulating the toxicokinetics of
chemicals in mixtures. Toxicology and Applied Pharmacology 2000,
167:199-209.
33. Ogata M, Fiserova-Bergerova V, Droz PO: Biological monitoring VII:
Occupational exposures to mixtures of industrial chemicals. Applied
Occupational and Environmental Hygiene 1993, 8:609-617.
34. Dobrev ID, Andersen ME, Yang RSH: Assessing interaction thresholds for
trichloroethylene in combination with tetrachloroethylene and 1,1,1-
trichloroethane using gas uptake studies and PBPK modeling. Archives of
Toxicology 2001, 75:134-144.
35. Dobrev ID, Andersen ME, Yang RSH: In silico toxicology: Simulating
interaction thresholds for human exposure to mixtures of
trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane.
Environmental Health Perspectives 2002, 110:1031-1039.
36. Dennison JE, Bigelow PL, Mumtaz MM, Andersen ME, Dobrev ID, Yang RSH:
Evaluation of potential toxicity from co-exposure to three CNS
depressants (toluene, ethylbenzene, and xylene) under resting and
working conditions using PBPK modeling. Journal of Occupational and
Environmental Hygiene 2005, 2:127-135.
37. Sarigiannis DA, Gotti A: Biology-based dose-response models for health
risk assessment of chemical mixtures. Fresenius Environmental Bulletin
2008, 17:1439-1451.
38. Verhaar HJM, Morroni JR, Reardon KF, Hays SM, Gaver DP Jr, Carpenter RL,
Yang RSH: A proposed approach to study the toxicology of complex
mixtures of petroleum products: The integrated use of QSAR, lumping
analysis and PBPK/PD modeling. Environmental Health Perspectives 1997,
105:179-195.
39. Collins FS, Gray GM, Bucher JR: Transforming environmental health
protection. Science 2008, 319:906-907.
40. Krautter M: Greenpeace Bewertungssystem für Pestizidrückstände,
überarbeitete Fassung. 2006, 3[http://www.greenpeace.de/fileadmin/gpd/
user_upload/themen/umweltgifte/greenpeace_bewertung_pestizide_neu.
pdf].
41. Kortenkamp A, Backhaus T, Faust M: State of the art report on mixture
toxicity. EC DG ENV; 2009.
42. Sarigiannis D, Marafante E, Gotti A, Reale GC: Reflections on new
directions for risk assessment of environmental chemical mixtures.
International Journal of Risk Assessment and Management 2009, 13:216-241.
43. NRC: Toxicity Testing in the 21st Century: A Vision and a Strategy.
Washington D.C: National Research Council; 2007, 216.
doi:10.1186/1476-069X-11-S1-S18
Cite this article as: Sarigiannis and Hansen: Considering the cumulative
risk of mixtures of chemicals – A challenge for policy makers.
Environmental Health 2012 11(Suppl 1):S18.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sarigiannis and Hansen Environmental Health 2012, 11(Suppl 1):S18
http://www.ehjournal.net/content/11/S1/S18
Page 12 of 12